Transdiagnostic versus Diagnosis-Specific Group Cognitive Behavioral Therapy for Anxiety Disorders and Depression: A Randomized Controlled Trial

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Transdiagnostic versus Diagnosis-Specific Group Cognitive Behavioral Therapy for Anxiety Disorders and Depression : A Randomized Controlled Trial. / Reinholt, Nina; Hvenegaard, Morten; Christensen, A. B.; Eskildsen, Anita; Hjorthoj, Carsten; Poulsen, Stig; Arendt, Mikkel Berg; Rosenberg, Nicole Kristjansen; Gryesten, Jasmin Rejaye; Aharoni, Ruth Nielsen; Alro, Anja Johnsen; Christensen, Clas Winding; Arnfred, Sidse Marie.

I: Psychotherapy and Psychosomatics, Bind 91, 2022, s. 36–49.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Reinholt, N, Hvenegaard, M, Christensen, AB, Eskildsen, A, Hjorthoj, C, Poulsen, S, Arendt, MB, Rosenberg, NK, Gryesten, JR, Aharoni, RN, Alro, AJ, Christensen, CW & Arnfred, SM 2022, 'Transdiagnostic versus Diagnosis-Specific Group Cognitive Behavioral Therapy for Anxiety Disorders and Depression: A Randomized Controlled Trial', Psychotherapy and Psychosomatics, bind 91, s. 36–49. https://doi.org/10.1159/000516380

APA

Reinholt, N., Hvenegaard, M., Christensen, A. B., Eskildsen, A., Hjorthoj, C., Poulsen, S., Arendt, M. B., Rosenberg, N. K., Gryesten, J. R., Aharoni, R. N., Alro, A. J., Christensen, C. W., & Arnfred, S. M. (2022). Transdiagnostic versus Diagnosis-Specific Group Cognitive Behavioral Therapy for Anxiety Disorders and Depression: A Randomized Controlled Trial. Psychotherapy and Psychosomatics, 91, 36–49. https://doi.org/10.1159/000516380

Vancouver

Reinholt N, Hvenegaard M, Christensen AB, Eskildsen A, Hjorthoj C, Poulsen S o.a. Transdiagnostic versus Diagnosis-Specific Group Cognitive Behavioral Therapy for Anxiety Disorders and Depression: A Randomized Controlled Trial. Psychotherapy and Psychosomatics. 2022;91:36–49. https://doi.org/10.1159/000516380

Author

Reinholt, Nina ; Hvenegaard, Morten ; Christensen, A. B. ; Eskildsen, Anita ; Hjorthoj, Carsten ; Poulsen, Stig ; Arendt, Mikkel Berg ; Rosenberg, Nicole Kristjansen ; Gryesten, Jasmin Rejaye ; Aharoni, Ruth Nielsen ; Alro, Anja Johnsen ; Christensen, Clas Winding ; Arnfred, Sidse Marie. / Transdiagnostic versus Diagnosis-Specific Group Cognitive Behavioral Therapy for Anxiety Disorders and Depression : A Randomized Controlled Trial. I: Psychotherapy and Psychosomatics. 2022 ; Bind 91. s. 36–49.

Bibtex

@article{e962ed593a8143a29a664290da6f028b,
title = "Transdiagnostic versus Diagnosis-Specific Group Cognitive Behavioral Therapy for Anxiety Disorders and Depression: A Randomized Controlled Trial",
abstract = "Introduction: The Unified Protocol for Transdiagnostic Treatment of Emotional Disorders (UP) delivered in a group format could facilitate the implementation of evidence-based psychological treatments. Objective: This study compared the efficacy of group UP and diagnosis-specific cognitive behavioral therapy (dCBT) for anxiety and depression in outpatient mental health services. Methods: In this pragmatic, multi-center, single-blinded, non-inferiority, randomized controlled trial (RCT), we assigned 291 patients with major depressive disorder, social anxiety disorder, panic disorder, or agoraphobia to 14 weekly sessions in mixed-diagnosis UP or single-diagnosis dCBT groups. The primary test was non-inferiority, using a priori criteria, on the World Health Organisation 5 Well-Being Index (WHO-5) at the end of the treatment. Secondary outcomes were functioning and symptoms. We assessed outcomes at baseline, end-of-treatment, and at a 6-month follow-up. A modified per-protocol analysis was performed. Results: At end-of-treatment, WHO-5 mean scores for patients in UP (n = 148) were non-inferior to those of patients in dCBT (n = 143; mean difference -2.94; 95% CI -8.10 to 2.21). Results were inconclusive for the WHO-5 at the 6-month follow-up. Results for secondary outcomes were non-inferior at end-of-treatment and the 6-month follow-up. Client satisfaction and rates of attrition, response, remission, and deterioration were similar across conditions. Conclusions: This RCT demonstrated non-inferior acute-phase outcomes of group-delivered UP compared with dCBT for major depressive disorder, social anxiety disorder, panic disorder, and agoraphobia in outpatient mental health services. The long-term effects of UP on well-being need further investigation. If study findings are replicated, UP should be considered a viable alternative to dCBT for common anxiety disorders and depression in outpatient mental health services.",
keywords = "Cognitive behavioral group therapy, Anxiety, Depression, Randomized controlled non-inferiority trial, Mental health service, EMOTIONAL DISORDERS, UNIFIED PROTOCOL, NON-INFERIORITY, PSYCHOTHERAPY, METAANALYSIS, POPULATION, EFFICACY, SCALE",
author = "Nina Reinholt and Morten Hvenegaard and Christensen, {A. B.} and Anita Eskildsen and Carsten Hjorthoj and Stig Poulsen and Arendt, {Mikkel Berg} and Rosenberg, {Nicole Kristjansen} and Gryesten, {Jasmin Rejaye} and Aharoni, {Ruth Nielsen} and Alro, {Anja Johnsen} and Christensen, {Clas Winding} and Arnfred, {Sidse Marie}",
year = "2022",
doi = "10.1159/000516380",
language = "English",
volume = "91",
pages = "36–49",
journal = "Psychotherapy and Psychosomatics",
issn = "0033-3190",
publisher = "S Karger AG",

}

RIS

TY - JOUR

T1 - Transdiagnostic versus Diagnosis-Specific Group Cognitive Behavioral Therapy for Anxiety Disorders and Depression

T2 - A Randomized Controlled Trial

AU - Reinholt, Nina

AU - Hvenegaard, Morten

AU - Christensen, A. B.

AU - Eskildsen, Anita

AU - Hjorthoj, Carsten

AU - Poulsen, Stig

AU - Arendt, Mikkel Berg

AU - Rosenberg, Nicole Kristjansen

AU - Gryesten, Jasmin Rejaye

AU - Aharoni, Ruth Nielsen

AU - Alro, Anja Johnsen

AU - Christensen, Clas Winding

AU - Arnfred, Sidse Marie

PY - 2022

Y1 - 2022

N2 - Introduction: The Unified Protocol for Transdiagnostic Treatment of Emotional Disorders (UP) delivered in a group format could facilitate the implementation of evidence-based psychological treatments. Objective: This study compared the efficacy of group UP and diagnosis-specific cognitive behavioral therapy (dCBT) for anxiety and depression in outpatient mental health services. Methods: In this pragmatic, multi-center, single-blinded, non-inferiority, randomized controlled trial (RCT), we assigned 291 patients with major depressive disorder, social anxiety disorder, panic disorder, or agoraphobia to 14 weekly sessions in mixed-diagnosis UP or single-diagnosis dCBT groups. The primary test was non-inferiority, using a priori criteria, on the World Health Organisation 5 Well-Being Index (WHO-5) at the end of the treatment. Secondary outcomes were functioning and symptoms. We assessed outcomes at baseline, end-of-treatment, and at a 6-month follow-up. A modified per-protocol analysis was performed. Results: At end-of-treatment, WHO-5 mean scores for patients in UP (n = 148) were non-inferior to those of patients in dCBT (n = 143; mean difference -2.94; 95% CI -8.10 to 2.21). Results were inconclusive for the WHO-5 at the 6-month follow-up. Results for secondary outcomes were non-inferior at end-of-treatment and the 6-month follow-up. Client satisfaction and rates of attrition, response, remission, and deterioration were similar across conditions. Conclusions: This RCT demonstrated non-inferior acute-phase outcomes of group-delivered UP compared with dCBT for major depressive disorder, social anxiety disorder, panic disorder, and agoraphobia in outpatient mental health services. The long-term effects of UP on well-being need further investigation. If study findings are replicated, UP should be considered a viable alternative to dCBT for common anxiety disorders and depression in outpatient mental health services.

AB - Introduction: The Unified Protocol for Transdiagnostic Treatment of Emotional Disorders (UP) delivered in a group format could facilitate the implementation of evidence-based psychological treatments. Objective: This study compared the efficacy of group UP and diagnosis-specific cognitive behavioral therapy (dCBT) for anxiety and depression in outpatient mental health services. Methods: In this pragmatic, multi-center, single-blinded, non-inferiority, randomized controlled trial (RCT), we assigned 291 patients with major depressive disorder, social anxiety disorder, panic disorder, or agoraphobia to 14 weekly sessions in mixed-diagnosis UP or single-diagnosis dCBT groups. The primary test was non-inferiority, using a priori criteria, on the World Health Organisation 5 Well-Being Index (WHO-5) at the end of the treatment. Secondary outcomes were functioning and symptoms. We assessed outcomes at baseline, end-of-treatment, and at a 6-month follow-up. A modified per-protocol analysis was performed. Results: At end-of-treatment, WHO-5 mean scores for patients in UP (n = 148) were non-inferior to those of patients in dCBT (n = 143; mean difference -2.94; 95% CI -8.10 to 2.21). Results were inconclusive for the WHO-5 at the 6-month follow-up. Results for secondary outcomes were non-inferior at end-of-treatment and the 6-month follow-up. Client satisfaction and rates of attrition, response, remission, and deterioration were similar across conditions. Conclusions: This RCT demonstrated non-inferior acute-phase outcomes of group-delivered UP compared with dCBT for major depressive disorder, social anxiety disorder, panic disorder, and agoraphobia in outpatient mental health services. The long-term effects of UP on well-being need further investigation. If study findings are replicated, UP should be considered a viable alternative to dCBT for common anxiety disorders and depression in outpatient mental health services.

KW - Cognitive behavioral group therapy

KW - Anxiety

KW - Depression

KW - Randomized controlled non-inferiority trial

KW - Mental health service

KW - EMOTIONAL DISORDERS

KW - UNIFIED PROTOCOL

KW - NON-INFERIORITY

KW - PSYCHOTHERAPY

KW - METAANALYSIS

KW - POPULATION

KW - EFFICACY

KW - SCALE

U2 - 10.1159/000516380

DO - 10.1159/000516380

M3 - Journal article

C2 - 34111874

VL - 91

SP - 36

EP - 49

JO - Psychotherapy and Psychosomatics

JF - Psychotherapy and Psychosomatics

SN - 0033-3190

ER -

ID: 273125008